111 related articles for article (PubMed ID: 27082859)
21. Neurosurgical experience of managing optic pathway gliomas.
Hill CS; Khan M; Phipps K; Green K; Hargrave D; Aquilina K
Childs Nerv Syst; 2021 Jun; 37(6):1917-1929. PubMed ID: 33532921
[TBL] [Abstract][Full Text] [Related]
22. Long-term visual outcome after chemotherapy for optic pathway glioma in children: Site and age are strongly predictive.
Dodgshun AJ; Elder JE; Hansford JR; Sullivan MJ
Cancer; 2015 Dec; 121(23):4190-6. PubMed ID: 26280460
[TBL] [Abstract][Full Text] [Related]
23. Risk of optic pathway glioma in children with neurofibromatosis type 1 and optic nerve tortuosity or nerve sheath thickening.
Levin MH; Armstrong GT; Broad JH; Zimmerman R; Bilaniuk LT; Feygin T; Li Y; Liu GT; Fisher MJ
Br J Ophthalmol; 2016 Apr; 100(4):510-4. PubMed ID: 26294105
[TBL] [Abstract][Full Text] [Related]
24. Pediatric Optic Pathway Gliomas Resource Utilization and Prevalence in the OptumLabs Data Warehouse.
Stoddard-Bennett TN; Yu F; Spiegel SJ; Perez CF; Coleman AL; Repka MX; Pineles SL
J Neuroophthalmol; 2024 Mar; 44(1):10-15. PubMed ID: 37505911
[TBL] [Abstract][Full Text] [Related]
25. Visual acuity of children treated with chemotherapy for optic pathway gliomas.
Kalin-Hajdu E; Décarie JC; Marzouki M; Carret AS; Ospina LH
Pediatr Blood Cancer; 2014 Feb; 61(2):223-7. PubMed ID: 23956233
[TBL] [Abstract][Full Text] [Related]
26. Nerve growth factor improves visual loss in childhood optic gliomas: a randomized, double-blind, phase II clinical trial.
Falsini B; Chiaretti A; Rizzo D; Piccardi M; Ruggiero A; Manni L; Soligo M; Dickmann A; Federici M; Salerni A; Timelli L; Guglielmi G; Lazzareschi I; Caldarelli M; Galli-Resta L; Colosimo C; Riccardi R
Brain; 2016 Feb; 139(Pt 2):404-14. PubMed ID: 26767384
[TBL] [Abstract][Full Text] [Related]
27. The effect of chemotherapy on optic pathway gliomas and their sub-components: A volumetric MR analysis study.
Shofty B; Mauda-Havakuk M; Weizman L; Constantini S; Ben-Bashat D; Dvir R; Pratt LT; Joskowicz L; Kesler A; Yalon M; Ravid L; Ben-Sira L
Pediatr Blood Cancer; 2015 Aug; 62(8):1353-9. PubMed ID: 25858021
[TBL] [Abstract][Full Text] [Related]
28. [Neurofibromatosis type 1 and optic pathway gliomas. A series of 80 patients].
Pascual-Castroviejo I; Pascual-Pascual SI; Velázquez-Fragua R; Viaño J; García-Segura JM; Botella MP
Rev Neurol; 2008 May 1-15; 46(9):530-6. PubMed ID: 18446694
[TBL] [Abstract][Full Text] [Related]
29. Optic glioma in children: a retrospective analysis of 101 cases.
Varan A; Batu A; Cila A; Soylemezoğlu F; Balcı S; Akalan N; Zorlu F; Akyüz C; Kutluk T; Büyükpamukçu M
Am J Clin Oncol; 2013 Jun; 36(3):287-92. PubMed ID: 22547006
[TBL] [Abstract][Full Text] [Related]
30. Optical coherence tomography in the diagnosis of optic pathway gliomas.
Parrozzani R; Clementi M; Kotsafti O; Miglionico G; Trevisson E; Orlando G; Pilotto E; Midena E
Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):8112-8. PubMed ID: 24169000
[TBL] [Abstract][Full Text] [Related]
31. Optic pathway gliomas in children with and without neurofibromatosis 1.
Czyzyk E; Jóźwiak S; Roszkowski M; Schwartz RA
J Child Neurol; 2003 Jul; 18(7):471-8. PubMed ID: 12940652
[TBL] [Abstract][Full Text] [Related]
32. Neuroophthalmological management of optic pathway gliomas.
Lee AG
Neurosurg Focus; 2007; 23(5):E1. PubMed ID: 18004957
[TBL] [Abstract][Full Text] [Related]
33. Optic Gliomas in Neurofibromatosis Type 1.
Parkhurst E; Abboy S
J Pediatr Ophthalmol Strabismus; 2016 Nov; 53(6):334-338. PubMed ID: 27537249
[TBL] [Abstract][Full Text] [Related]
34. [Preoperative diagnosis and microsurgery of the optic gliomas:retrospective analysis of 7 patients].
Liu B; Liang YS; Shi XE; Zhang QJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 37(6):645-7. PubMed ID: 16378121
[TBL] [Abstract][Full Text] [Related]
35. [Apropos of 5 cases of optic nerve tumors diagnosed during a 6-year-period].
Rebika S; Bonnin N; Kémény JL; Chiambaretta F; Bacin F
J Fr Ophtalmol; 2015 Jan; 38(1):13-21. PubMed ID: 25542442
[TBL] [Abstract][Full Text] [Related]
36. Magnetic resonance imaging findings in children with spasmus nutans.
Bowen M; Peragallo JH; Kralik SF; Poretti A; Huisman TAGM; Soares BP
J AAPOS; 2017 Apr; 21(2):127-130. PubMed ID: 28284856
[TBL] [Abstract][Full Text] [Related]
37. Does chemotherapy affect the visual outcome in children with optic pathway glioma? A systematic review of the evidence.
Moreno L; Bautista F; Ashley S; Duncan C; Zacharoulis S
Eur J Cancer; 2010 Aug; 46(12):2253-9. PubMed ID: 20400294
[TBL] [Abstract][Full Text] [Related]
38. Spontaneous Regression of a Massive Sporadic Chiasmal Optic Pathway Glioma.
Pruzan NL; de Alba Campomanes A; Gorovoy IR; Hoyt C
J Child Neurol; 2015 Aug; 30(9):1196-8. PubMed ID: 25260914
[TBL] [Abstract][Full Text] [Related]
39. Low-dose cisplatin-etoposide regimen for patients with optic pathway glioma: a report of four cases and literature review.
Cardellicchio S; Bacci G; Farina S; Genitori L; Massimino M; de Martino M; Caputo R; Sardi I
Neuropediatrics; 2014 Feb; 45(1):42-9. PubMed ID: 24272769
[TBL] [Abstract][Full Text] [Related]
40. [Long-term outcome of gliomas of the visual pathway in type 1 neurofibromatosis].
Schröder S; Baumann-Schröder U; Hazim W; Haase W; Mautner VF
Klin Monbl Augenheilkd; 1999 Dec; 215(6):349-54. PubMed ID: 10637799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
